BehaveNet^®
Clinical Capsule™

Join Our Mailing List

For Email Newsletters you can trust

Movies

Opinion

Facebook

Twitter

drug: fospropofol

Clinical class	sedative hypnotic, general anesthetic
Action	central nervous system depressant
Chemical class
CSA schedule	pending
DEA number
NDC
Routes of administration	parenteral
Associated with (substance-related)	disorders
Availability	hospital
Active metabolite	prodrug (dephosphorilated by alkaline phosphatase to) propofol

U.S. Preparations:

Lusedra™ (Eisai) FDA approved for:
12.12.2008 monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.
U.S. Prescribing information

BehaveNet® Clinical Capsule™

drug: fospropofol

U.S. Preparations:

BehaveNet^®
Clinical Capsule™